Check the Noni B release: Ebitda to sales % over 10% LFL sales growth 3% Cash conversion of EBITDA to operating cash flow over 100% https://www.asx.com.au/asxpdf/20180228/pdf/43s07lnvfz102z.pdf
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution